# CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

> **NCT00122772** · PHASE3 · COMPLETED · sponsor: **International Atomic Energy Agency** · enrollment: 601 (actual)

## Conditions studied

- Cervix Cancer

## Interventions

- **RADIATION:** Radiotherapy
- **RADIATION:** Radiotherapy
- **RADIATION:** Radiotherapy/Cisplatin
- **RADIATION:** Radiotherapy/Cisplatin

## Key facts

- **NCT ID:** NCT00122772
- **Lead sponsor:** International Atomic Energy Agency
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2011-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122772, "CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00122772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*